` Comparison: 20B vs CAI - Alpha Spread

B
20B
vs
C
CAI

Over the past 12 months, 20B has significantly outperformed CAI, delivering a return of +150% compared to the CAI's 36% drop.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
20B
CAI
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

20B Intrinsic Value
LOCKED
Unlock
CAI Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
B
BioMark Diagnostics Inc
SWB:20B
0.35 EUR
C
Caris Life Sciences Inc
NASDAQ:CAI
18.05 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
20B, CAI

20B
CAI
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
B
BioMark Diagnostics Inc
Revenue
C
Caris Life Sciences Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
20B, CAI

20B
CAI
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
B
BioMark Diagnostics Inc
SWB:20B
C
Caris Life Sciences Inc
NASDAQ:CAI
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

20B
0%
CAI
66.6%

Operating Margin

20B
-2 304.4%
CAI
5.6%

Net Margin

20B
-1 851.5%
CAI
-66.2%

FCF Margin

20B
-2 233.4%
CAI
8.2%

ROE

20B
576.3%
CAI
-93.2%

ROA

20B
-112.8%
CAI
-47.8%

ROIC

20B
-451.2%
CAI
15.7%

ROCE

20B
-1 641.8%
CAI
4.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
20B, CAI

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
20B, CAI

Performance Gap Between 20B and CAI
LOCKED
Unlock

Performance By Year
20B, CAI

Loading
20B
CAI
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 20B to other stocks
NTRA
Natera Inc
Cheaper
vs 20B
EXAS
Exact Sciences Corp
Cheaper
vs 20B
BIM
Biomerieux SA
Cheaper
vs 20B
GH
Guardant Health Inc
Cheaper
vs 20B
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett